Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Preferred Shares (2022 - 2025)

InspireMD filings provide 4 years of Preferred Shares readings, the most recent being $11.0 million for Q3 2025.

  • On a quarterly basis, Preferred Shares rose 99900.0% to $11.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $11.0 million, a 99900.0% increase, with the full-year FY2024 number at $11.0 million, changed 0.0% from a year prior.
  • Preferred Shares hit $11.0 million in Q3 2025 for InspireMD, up from $10997.0 in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $11.0 million in Q4 2023 to a low of $10997.0 in Q4 2022.
  • Median Preferred Shares over the past 4 years was $10997.0 (2022), compared with a mean of $3.7 million.
  • Biggest five-year swings in Preferred Shares: surged 99900.0% in 2023 and later changed 0.0% in 2024.
  • InspireMD's Preferred Shares stood at $10997.0 in 2022, then surged by 99900.0% to $11.0 million in 2023, then changed by 0.0% to $11.0 million in 2024, then changed by 0.0% to $11.0 million in 2025.
  • The last three reported values for Preferred Shares were $11.0 million (Q3 2025), $10997.0 (Q2 2025), and $10997.0 (Q1 2025) per Business Quant data.